Pharma Industry News

Doctor-turned-dealmaker reveals his M&A playbook

1 week ago
Add Comment
by David Miller
947 Views

Dr. David Hung is pulling multiple financial levers to put Nuvation Bio on strong footing as it advances its oncology drugs.

Dr. David Hung is pulling multiple financial levers to put Nuvation Bio on strong footing as it advances its oncology drugs.

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

Leave a Comment

[mwai_chat window="true" fullscreen="true"]